Insider · CIK 0001294693
Marc Benioff
ceochairofficerdirector
Files at CRM (Salesforce, Inc.). First filing Dec 20, 2024, latest Dec 20, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $110M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRM: Salesforce, Inc.
CRMOct 9, 2026 · close 229.13
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Salesforce, Inc. | $110M 317,105 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | CRM Salesforce, Inc. | GGift Common Stock | -300,000 | $0.00 | $0 | 11,862,457 | Dec 26, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | MOption exercise Common Stock | +317,105 | $118.04 | $37M | 12,479,562 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -4,900 | $336.16 | $1.6M | 12,474,662 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -35,695 | $337.26 | $12M | 12,438,967 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -25,767 | $338.07 | $8.7M | 12,413,200 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -5,901 | $338.98 | $2.0M | 12,407,299 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -2,975 | $340.16 | $1.0M | 12,404,324 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -5,421 | $341.30 | $1.9M | 12,398,903 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -4,405 | $342.29 | $1.5M | 12,394,498 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -8,854 | $343.59 | $3.0M | 12,385,644 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -15,769 | $344.44 | $5.4M | 12,369,875 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -5,614 | $345.44 | $1.9M | 12,364,261 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -6,934 | $346.33 | $2.4M | 12,357,327 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -14,788 | $347.67 | $5.1M | 12,342,539 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -15,443 | $348.61 | $5.4M | 12,327,096 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -20,892 | $349.69 | $7.3M | 12,306,204 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -40,546 | $350.61 | $14M | 12,265,658 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -57,941 | $351.36 | $20M | 12,207,717 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -25,927 | $352.51 | $9.1M | 12,181,790 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -14,901 | $353.51 | $5.3M | 12,166,889 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | SOpen-market sale Common Stock | -4,432 | $354.45 | $1.6M | 12,162,457 | Dec 20, 2024 |
| Dec 18, 2024 | CRM Salesforce, Inc. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -317,105 | $0.00 | $0 | 0 | Dec 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.